ArticleCureus2025
Obstructive Uropathy From a Pelvic Lymphocele After Robotic-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphocele formation after pelvic lymph node dissection (PLND) in radical prostatectomy (RP) is a well-recognized but often underestimated complication. Although most lymphoceles remain asymptomatic, those that become symptomatic can be troublesome and even life-threatening if venous thromboembolism occurs. We present the case of a 68-year-old man with prostate cancer who underwent an uneventful robotic-assisted RP (RaRP) with bilateral PLND. One month later, he presented with right flank pain, leukocytosis, and acute kidney injury. Imaging revealed large lymphoceles causing right hydronephrosis. A right ureteral stent was placed, immediately relieving symptoms and restoring renal function. At three-month follow-up, a computed tomography (CT) scan demonstrated partial regression of the lymphoceles, and the patient remained symptom-free after stent removal. This case demonstrates alternative management for lymphocele-related complications when it comes to obstructive uropathy using an internal stent to relieve the patient's symptoms, an option that has not been previously documented in the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.